Waverton Investment Management Ltd Purchases 166 Shares of HCA Healthcare, Inc. $HCA

Waverton Investment Management Ltd grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.1% in the 2nd quarter, Holdings Channel.com reports. The fund owned 113,306 shares of the company’s stock after acquiring an additional 166 shares during the period. Waverton Investment Management Ltd’s holdings in HCA Healthcare were worth $43,385,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare during the first quarter valued at $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare during the first quarter valued at $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter worth about $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare in the 2nd quarter worth about $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare in the 2nd quarter worth about $27,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 0.3%

HCA stock opened at $472.97 on Thursday. The business’s 50-day moving average price is $425.01 and its 200-day moving average price is $389.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $478.19. The stock has a market cap of $107.93 billion, a P/E ratio of 18.28, a PEG ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the firm earned $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Analyst Upgrades and Downgrades

Several research firms recently commented on HCA. Sanford C. Bernstein reiterated a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Stephens raised their target price on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Morgan Stanley set a $425.00 target price on HCA Healthcare in a research report on Monday, October 27th. Finally, KeyCorp raised their target price on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.